P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA.

por R, Chethan, Singh Malik, Prabath, Kumar Sahoo, Ranjit, Pramannik, Raja, Garg, Vikas, Kirar, Sudhir, Bhatia, Kanupriya, Kantak, Anura, Sharma, Atul, Kumar, Lalit
Publicado 2023